COCP
Cocrystal Pharma, Inc.
+0.01 (+0.90%)1.15USD4.1K成交股數22.2M市值–本益比(近四季)16.6股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 105K | 225K | – | 498K | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 2.1M | 1.4M | 1.6M | 954K | 1.1M | 1.4M | 3.2M | 4.3M | 3.0M | 4.3M | 4.2M | 2.8M |
| 銷售管理費用 | 1.1M | 1.2M | 862K | 1.1M | 986K | 981K | 1.8M | 1.1M | 1.2M | 1.4M | 1.8M | 1.5M |
| 營業利益 | −3.2M+51% | −2.4M+1% | −2.5M-51% | −2.1M-62% | −2.1M-49% | −2.3M-50% | −5.0M+13% | −5.4M+26% | −4.2M | −4.7M | −4.4M | −4.3M |
| 營業利益率 | -3,032.4% | -1,047.1% | – | -419.5% | – | – | – | – | – | – | – | – |
| 稅後淨利 | −3.2M+54% | −2.3M-0% | −2.4M-51% | −2.0M-62% | −2.1M-48% | −2.3M-48% | −4.9M+19% | −5.3M+28% | −4.0M | −4.5M | −4.2M | −4.2M |
| 淨利率 | -3,013.3% | -1,021.8% | – | -411.4% | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.23+15% | -0.17-26% | -0.16-67% | -0.19-64% | -0.20-49% | -0.23-44% | -0.49+20% | -0.53+29% | -0.39 | -0.41 | -0.41 | -0.41 |
| 稀釋股數 | 13.8M | 13.8M | 11.3M | 11.0M | 10.2M | 10.2M | 10.2M | 10.2M | 10.2M | 9.7M | 10.2M | 10.1M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | – | – | 7.0M | – | – | – | 13.1M | 18.1M | 21.8M | 26.4M | 29.7M | 32.4M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 4.6M | 7.4M | 9.7M | 10.4M | 8.5M | 10.7M | 16.2M | 21.6M | 26.5M | 31.3M | 32.6M | 36.3M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 3.6M | 3.3M | 3.4M | 2.8M | 3.2M | 3.4M | 3.5M | 4.2M | 4.0M | 4.9M | 1.9M | 1.6M |
| 股東權益 | 1.0M | 4.1M | 6.3M | 7.7M | 5.3M | 7.3M | 12.7M | 17.4M | 22.6M | 26.4M | 30.7M | 34.7M |
| 負債比 | 77.5% | 44.6% | 34.8% | 26.6% | 37.3% | 31.5% | 21.7% | 19.4% | 14.9% | 15.6% | 5.9% | 4.4% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −2.3M-20% | – | – | – | −2.9M | – | – | −4.5M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | 8K | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | −4.5M | – | – | – |
| 折舊攤銷 | – | 12K | – | – | – | 25K | – | – | 35K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2019 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2019 年度 · 358K
| Collaboration Services | 358K | 100.0% | – |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −8.8M | –% | -0.78 | −8.2M |
| FY2024 | – | – | −17.5M | –% | -1.72 | −16.5M |
| FY2023 | – | – | −18.0M | –% | -1.87 | −14.8M |
| FY2022 | – | – | −38.8M | –% | -4.77 | −21.5M |
| FY2021 | – | – | −14.2M | –% | -0.16 | −12.8M |
| FY2020 | 2.0M | -69.3% | −9.6M | -479.0% | -0.17 | −10.1M |
| FY2019 | 6.6M | -11417.2% | −48.2M | -733.8% | -1.51 | −1.7M |
| FY2018 | −58K | – | −49.0M | 84,565.5% | -1.75 | −8.3M |